Geneoscopy company profile
Cancer Prevention | Diagnostics | Precision Medicine
About Geneoscopy
Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker platform, Geneoscopy’s mission is to empower patients and providers to transform gastrointestinal health through innovative diagnostics. The company’s FDA-approved ColoSense™ test uses a proprietary RNA-based platform to screen for colorectal cancer and advanced adenomas for average-risk individuals over the age of 45. In partnership with leading universities and biopharmaceutical companies, Geneoscopy is also developing diagnostic tests for treatment selection and therapy monitoring in other GI disease areas.
Mission and direction
Geneoscopy is a life sciences diagnostics company developing innovative RNA-based tests to improve gastrointestinal health. Using its proprietary stool-derived biomarker platform, it creates screening and monitoring solutions that help detect colorectal cancer and other GI diseases earlier, support treatment selection, and enable better care for patients and providers.
Company values
- Integrity
- Courage
- Agility
- Passion
- Collaboration